PNTG vs. SHC, BTSG, VCYT, LFST, CON, PRVA, SGRY, ADUS, PACS, and ARDT
Should you be buying The Pennant Group stock or one of its competitors? The main competitors of The Pennant Group include Sotera Health (SHC), BrightSpring Health Services (BTSG), Veracyte (VCYT), LifeStance Health Group (LFST), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), Surgery Partners (SGRY), Addus HomeCare (ADUS), PACS Group (PACS), and Ardent Health Partners (ARDT). These companies are all part of the "healthcare" industry.
The Pennant Group vs.
The Pennant Group (NASDAQ:PNTG) and Sotera Health (NASDAQ:SHC) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their community ranking, risk, media sentiment, valuation, dividends, institutional ownership, analyst recommendations, earnings and profitability.
Sotera Health received 9 more outperform votes than The Pennant Group when rated by MarketBeat users. Likewise, 57.65% of users gave Sotera Health an outperform vote while only 45.98% of users gave The Pennant Group an outperform vote.
Sotera Health has a net margin of 6.31% compared to The Pennant Group's net margin of 3.24%. Sotera Health's return on equity of 42.27% beat The Pennant Group's return on equity.
The Pennant Group currently has a consensus target price of $36.00, indicating a potential upside of 30.25%. Sotera Health has a consensus target price of $16.08, indicating a potential upside of 17.48%. Given The Pennant Group's stronger consensus rating and higher possible upside, equities analysts plainly believe The Pennant Group is more favorable than Sotera Health.
85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 91.0% of Sotera Health shares are held by institutional investors. 5.8% of The Pennant Group shares are held by company insiders. Comparatively, 55.1% of Sotera Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
In the previous week, The Pennant Group had 1 more articles in the media than Sotera Health. MarketBeat recorded 1 mentions for The Pennant Group and 0 mentions for Sotera Health. The Pennant Group's average media sentiment score of 0.84 beat Sotera Health's score of 0.38 indicating that The Pennant Group is being referred to more favorably in the media.
Sotera Health has higher revenue and earnings than The Pennant Group. The Pennant Group is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.
The Pennant Group has a beta of 1.93, suggesting that its stock price is 93% more volatile than the S&P 500. Comparatively, Sotera Health has a beta of 1.92, suggesting that its stock price is 92% more volatile than the S&P 500.
Summary
Sotera Health beats The Pennant Group on 12 of the 18 factors compared between the two stocks.
Get The Pennant Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for PNTG and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
The Pennant Group Competitors List
Related Companies and Tools
This page (NASDAQ:PNTG) was last updated on 1/24/2025 by MarketBeat.com Staff
